Biovest emerges from bankruptcy again; Sabin begins vaccine discovery program;

> Biovest has emerged from bankruptcy for the second time and named a new CEO. News

> The Sabin Vaccine Institute has begun a soil-transmitted helminth vaccine discovery program. Release

> WHO believes a vaccine for malaria could be available in the next three years. Article

> Bulgaria is facing a shortage of childhood vaccines because a former manager failed to order the shots. Piece

> The outgoing Iranian president has inaugurated the country's first flu vaccine production line. Item

> Baxter ($BAX) and other developers of Lyme disease vaccines face scepticism from advocacy groups. Feature

> India has procured yellow fever vaccines from Sanofi ($SNY) to overcome the recent shortage. News

And Finally... Canada's NCIC Clinical Trials Group is to sponsor a Phase II study of Immunovaccine's cancer vaccine. Release

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.